SORAINEN Lithuania advised Softneta in negotiating and concluding agreements on investment in the company by venture capital fund Practica Capital. Softneta is an award-winning Lithuanian IT company providing software-based specialized healthcare solutions to improve the quality of patient care. The company has enjoyed great success not only nationally but also globally through exporting products to […]
February 2016 is expected to see the launch of a single market of medicines in the framework of the Eurasian Economic Union, which may be a game changer in the industry. Currently over 30 draft acts have been adopted, establishing EEU rules and principles for movement of medicines and covering such issues as registration, clinical […]
Dear clients and cooperation partners, Belarusian legislation in the healthcare and pharmaceuticals sector is continuing to undergo substantial changes. 2015 was rich with events, with even more expected to come. We offer below, in a few bullet points, our view on factors characterising the state of the Belarusian legislative environment in the pharma and healthcare […]
Dear clients and cooperation partners, Belarusian healthcare legislation is currently undergoing substantial changes. The reform primarily concerns circulation of pharmaceuticals but also touches upon other issues in the field of medicine and healthcare. The ongoing changes may be interesting for both patients and the business community. Below we offer a review of some changes to […]
Sorainen represented the European Commission jointly with members of the Commission’s legal service in proceedings before the Court of Justice of the European Union in Luxembourg under a preliminary reference (TFEU article 267). The case concerned a reference by an Estonian appeal court as to proper interpretation of the rules for fees on official controls […]